Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Defining the chromatin compaction state of all histone post-translational modifications

ABSTRACT: Defining the chromatin compaction state of all histone post-translational modifications

PROVIDER: PRJNA516172 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8466970_1.fastq.gz	Fastqsanger.gz
	SRR8466970_2.fastq.gz	Fastqsanger.gz
	SRR8466980_1.fastq.gz	Fastqsanger.gz
	SRR8466980_2.fastq.gz	Fastqsanger.gz
	SRR8466971_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 28

Similar Datasets

Mitotic post-translational modifications of histones promote chromatin compaction in vitro

Project description:As histones undergo major changes in their post-translational modifications during mitotic entry, we speculated that the spectrum of cell cycle-specific histone modifications might contribute to chromosome compaction during mitosis. To test this hypothesis, we isolated core histones from interphase and mitotic cells and reconstituted chromatin with them. We used mass spectrometry to show that key post-translational modifications remained intact during our isolation procedure.

2018-10-24 | PXD007116 | Pride

Defining the chromatin compaction state of all histone post-translational modifications

Project description:By performing metabolic incorporation of heavy labeled amino acids in cell culture, we estimated the turnover rates of histones decorated with different PTMs, and correlated this information with how “active” chromatin is where these PTMs reside.

2019-01-22 | GSE125384 | GEO

Post-translational modifications of MSA alpha-synuclein

Project description:LC-MS/MS analysis of post-translational modifications in alpha-synuclein of five MSA cases.

2020-04-09 | PXD018434 | JPOST Repository

Mitotic post-translational modifications of histones promote chromatin compaction in vitro.

Project description:How eukaryotic chromosomes are compacted during mitosis has been a leading question in cell biology since the nineteenth century. Non-histone proteins such as condensin complexes contribute to chromosome shaping, but appear not to be necessary for mitotic chromatin compaction. Histone modifications are known to affect chromatin structure. As histones undergo major changes in their post-translational modifications during mitotic entry, we speculated that the spectrum of cell-cycle-specific histone modifications might contribute to chromosome compaction during mitosis. To test this hypothesis, we isolated core histones from interphase and mitotic cells and reconstituted chromatin with them. We used mass spectrometry to show that key post-translational modifications remained intact during our isolation procedure. Light, atomic force and transmission electron microscopy analysis showed that chromatin assembled from mitotic histones has a much greater tendency to aggregate than chromatin assembled from interphase histones, even under low magnesium conditions where interphase chromatin remains as separate beads-on-a-string structures. These observations are consistent with the hypothesis that mitotic chromosome formation is a two-stage process with changes in the spectrum of histone post-translational modifications driving mitotic chromatin compaction, while the action of non-histone proteins such as condensin may then shape the condensed chromosomes into their classic mitotic morphology.

| S-EPMC5627050 | biostudies-literature

ChIP-seq validation of recombinant antibodies to histone post-translational modifications

Project description:Recombinant antibodies to histone post-translational modifications (PTMs), with their essentially infinite renewability, could fundamentally eliminate a major source of low reproducibility in epigenetics research. Here, we report new recombinant antibodies to trimethylated Lys4 and Lys9, respectively, on histone H3. Quantitative characterization demonstrated their exquisite specificity and high affinity, and they performed well in common epigenetics applications, including ChIP. These results demonstrate the feasibility of generating recombinant antibodies to a range of histone marks, which will accelerate epigenetics research. We characterized recombinant antibodies with native ChIP using HEK293 cells followed by deep sequencing.

2016-03-02 | E-GEOD-66530 | biostudies-arrayexpress

ChIP-seq validation of recombinant antibodies to histone post-translational modifications

2016-03-02 | GSE66530 | GEO

Post-translational modifications of Keap1: the state of the art.

Project description:The Keap1-Nrf2 signaling pathway plays a crucial role in cellular defense against oxidative stress-induced damage. Its activation entails the expression and transcriptional regulation of several proteins involved in detoxification and antioxidation processes within the organism. Keap1, serving as a pivotal transcriptional regulator within this pathway, exerts control over the activity of Nrf2. Various post-translational modifications (PTMs) of Keap1, such as alkylation, glycosylation, glutathiylation, S-sulfhydration, and other modifications, impact the binding affinity between Keap1 and Nrf2. Consequently, this leads to the accumulation of Nrf2 and its translocation to the nucleus, and subsequent activation of downstream antioxidant genes. Given the association between the Keap1-Nrf2 signaling pathway and various diseases such as cancer, neurodegenerative disorders, and diabetes, comprehending the post-translational modification of Keap1 not only deepens our understanding of Nrf2 signaling regulation but also contributes to the identification of novel drug targets and biomarkers. Consequently, this knowledge holds immense importance in the prevention and treatment of diseases induced by oxidative stress.

| S-EPMC10801156 | biostudies-literature

Mitochondrial ribosomal protein L12 (MRPL12) post-translational modifications

Project description:Analysis of post-translational modifications on mitochondrial protein L12 (MRPL12). MRPL12 was overexpressed in HeLa or HEK293 cells, immunoprecipitated, and subject to bottom-up proteomic analysis on an Agilent 6545 LC-qTOF.

2023-11-08 | MSV000093335 | MassIVE

Post-translational modifications of vaccine candidates of Cryptosporidium parvum

Project description:Here we describe the post translational modifications on vaccine candidate proteins from Cryptosporidium parvum. We have identified O-glycosylated peptides from GP15, GP40, GP900, and a novel mucin-like protein referred to as GP20. In addition, we have discovered that the immune dominant antigen, CP23, contains both N-myristoyl and C-palmitoyl modifications on the N-terminal region of the protein.

2017-08-14 | PXD005989 | Pride

Peptide collision cross section of 22 post-translational modifications

Project description:The present study investigates the ion mobility characteristics of synthetic peptides carrying 22 different post-translational modifications by Ion Mobility-Mass Spectrometry. Samples were kindly provided by the ProteomeTools project.

2023-08-25 | PXD042416 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data